The Dales Report – CEOs Kelsey Ramsden and Anthony Tennyson Talk Psychedelic Partnerships: “Further, Faster, Together”

Shadd Dales talked to the MINDCURE and Awakn CEOs about their partnership. MINDCURE will distribute Awakn’s ketamine-assisted psychotherapy as they expand into North America’s clinical market. iSTRYM’s data provision abilities will be central to accessing this market, and a boon for achieving care at scale. Furthermore, these companies are early industry movers, and Wonderland: Miami allows for collaborative growth.

Access the interview here.